Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort
HIV MEDICINE Volume: 20 Issue: 3 Pages: 237-247 DOI: 10.1111/hiv.12710
Llibre, JM; Montoliu, A ; Miro, JM ; Domingo, P ; Riera, M; Tiraboschi, J; Curran, A; Homar, F ; Ambrosioni, J ; Abdulghani, N; Force, L; Peraire, J; Casabona, J; Peraire, J ; Vilaro, J ; Masabeu, A ; Orti, AJ; and more ; PISCIS Cohort Group;
article